Fractionation schemes in adjuvant radiotherapy for breast cancer: review of the evidence and therapeutic approach at the National Institute of Cancerology, Colombia

被引:0
|
作者
Caicedo-Martinez, Maria [1 ]
del Castillo, Flavio Jose Rosero-Diaz [2 ]
Abi-Saab, Luis Guzman [3 ]
Briceno-Morales, Ximena [3 ]
Gamboa-Garay, oscar Andres [4 ]
Esguerra-Cantillo, Jose Alejandro [4 ]
Alvarez-Martinez, Alex [4 ]
Guerrero-Lizcano, Eduardo [4 ]
Ballesteros-Gomez, Holman [4 ]
Torres-Silva, Luis Angel [4 ]
Lehmann-Mosquera, Carlos [3 ]
Marino-Lozano, Ivan [3 ]
Garcia-Mora, Mauricio [3 ]
Aristizabal, Javier Angel [3 ]
Suarez-Rodriguez, Raul [3 ]
Duarte-Torres, Carlos Alfonso [3 ]
Diaz-Casas, Sandra Esperanza [3 ]
机构
[1] Univ Mil Nueva Granada, Inst Nacl Cancerol, Especializac Oncol Radioterap, Bogota, DC, Colombia
[2] Fdn Univ Ciencias Salud, Especializac Mastol, Inst Nacl Cancerol, Bogota, DC, Colombia
[3] Unidad Func Seno & Tejidos Blandos, Inst Nacl Cancerol, Bogota, DC, Colombia
[4] Inst Nacl Cancerol, Grp Area Oncol Radioterap, Bogota, DC, Colombia
来源
REVISTA COLOMBIANA DE CANCEROLOGIA | 2024年 / 28卷 / 01期
关键词
breast neoplasms; radiotherapy; treatment outcome; dose fractionation; radiation; radiation dose hypofractionation; female; postoperative care; UK STANDARDIZATION; FOLLOW-UP; CONSERVING SURGERY; IRRADIATION; WOMEN; TRIAL; HYPOFRACTIONATION; LUMPECTOMY; MASTECTOMY; OLDER;
D O I
10.35509/01239015.973
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radiotherapy is a fundamental component in the management of breast cancer, particularly in the adjuvant setting, as its benefits in the treatment of breast cancer in terms of local recurrence, disease -free survival, and overall survival have been widely demonstrated. Hypofractionated radiation schedules are the current standard of adjuvant treatment in patients with early -stage breast cancer. Thus, the Radiation Oncology Unit and the Functional Unit for Breast and Soft Tissue Tumors of the Instituto Nacional de Cancerologia (INC) (Bogota, Colombia) decided to review the evidence on the subject and establish indications for different hypofractionation schemes at the INC, both for patients with cancers in early stages and for those with locally advanced tumors.
引用
收藏
页数:82
相关论文
共 50 条
  • [41] Indications for the use of pertuzumab in non-metastatic HER2-positive breast cancer in the neoadjuvant and adjuvant. Review of the literature and therapeutic approach at the Instituto Nacional de Cancerologia - Colombia
    Quintero-Ortiz, Maria
    Ballen, Diego Felipe
    Briceno-Morales, Ximena
    Bruges-Maya, Ricardo
    Contreras-Mejia, Fernando
    Sanchez-Castillo, Jesus Oswaldo
    Guzman-Abisaab, Luis
    Rojas, Eduardo
    Marino-Lozano, Ivan
    Angel-Aristizabal, Javier
    Lehmann-Mosquera, Carlos
    Garcia-Mora, Mauricio
    Duarte-Torres, Carlos
    Diaz-Casas, Sandra E.
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2023, 27 : 16 - 25
  • [42] Follow-up of the patient with breast cancer history. Review of the evidence and approach at the Instituto Nacional de Cancerologia - Colombia
    Briceno-Morales, Ximena
    Zuluga-Liberato, Andrea
    Briceno-Morales, Clara
    Guzman-AbiSaabd, Luis
    Oswaldo Sanchez-Castillo, Jesus
    Bruges-Maya, Ricardo
    Lehmann-Mosquera, Carlos
    Garcia-Mora, Mauricio
    Angel-Aristizabal, Javier
    Fernando Marino-Lozano, Ivan
    Alfonso Duarte-Torres, Carlos
    Contreras-Mejia, Fernando
    Rojas, Eduardo
    Diaz-Casas, Sandra E.
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2023, 27 : 52 - 71
  • [43] Indications for adjuvant radiation therapy in breast cancer: a review of the evidence and recommendations for clinical practice
    Swanick, Cameron W.
    Smith, Benjamin D.
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (03)
  • [44] SURGERY PLUS ADJUVANT CHEMOTHERAPY - A REVIEW OF THERAPEUTIC IMPLICATIONS .1. BREAST-CANCER
    CARTER, SK
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 4 (03) : 147 - 163
  • [45] The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation
    Picot, Jo
    Copley, Vicky
    Colquitt, Jill L.
    Kalita, Neelam
    Hartwell, Debbie
    Bryant, Jackie
    HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (69) : 1 - +
  • [46] Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group
    Nielsen, Mette H.
    Berg, Martin
    Pedersen, Anders N.
    Andersen, Karen
    Glavicic, Vladimir
    Jakobsen, Erik H.
    Jensen, Ingelise
    Josipovic, Mirjana
    Lorenzen, Ebbe L.
    Nielsen, Hanne M.
    Stenbygaard, Lars
    Thomsen, Mette S.
    Vallentin, Susanne
    Zimmermann, Sune
    Offersen, Birgitte V.
    ACTA ONCOLOGICA, 2013, 52 (04) : 703 - 710
  • [47] Intraoperative radiotherapy in elderly patients with breast cancer: Is there a clinical applicability? Review of the current evidence
    Esposito, Emanuela
    Compagna, Rita
    Rinaldo, Massimo
    Falivene, Sara
    Ravo, Vincenzo
    Amato, Bruno
    Muto, Paolo
    D'Aiuto, Massimiliano
    INTERNATIONAL JOURNAL OF SURGERY, 2016, 33 : S88 - S91
  • [48] Adjuvant radiotherapy for low-risk early breast cancer in elderly women: evidence from randomized trials
    Burgos-Burgos, Javier
    Pinar-Sedeno, Beatriz
    Garcia-Cabrera, Laura
    Rodriguez-Ibarria, Nieves
    Cabezon-Pons, Auxiliadora
    Lloret-Saenz-Bravo, Marta
    Vicente-Rubio, Elena
    Vega-Benitez, Victor
    Travieso-Aja, Maria
    Lara, Pedro C.
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 : S207 - S216
  • [49] Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Through a Therapeutic Educational Approach: A Feasibility Study
    Bourmaud, Aurelie
    Rousset, Vanessa
    Regnier-Denois, Veronique
    Collard, Olivier
    Jacquin, Jean-Philippe
    Merrouche, Yacine
    Lapoirie, Joelle
    Tinquaut, Fabien
    Lataillade, Laurence
    Chauvin, Franck
    ONCOLOGY NURSING FORUM, 2016, 43 (03) : E94 - E103
  • [50] Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer
    Johnston, Stephen R. D.
    Tolaney, Sara M.
    O'Shaughnessy, Joyce
    Rastogi, Priya
    Harbeck, Nadia
    Martin, Miguel
    LANCET ONCOLOGY, 2023, 24 (06): : E238 - E238